1.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: WHC-MRI-GU-2006-097, NCT00397761
|
|
2.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 105-08-201, NCT00826085
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: 65 and under Sponsor: NCI Protocol IDs: CHNMC-05042, IRB 05042, NCT00182793
|
|
4.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0903-882, 0309006307, NCT00195091
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CHNMC-05015, IRB 05015, NCT00295893
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MUSC-101072, MUSC-HR-17111, 101072, NCT00499122
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: UWCC-6488, 6488, UWCC-UW-6488, UWCC-07-6437-H/A, NCT00513695
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 19 and over Sponsor: Other Protocol IDs: F061229006, UAB 0648, NCT00530868
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: LJCC 07-03, NCT00542191
|
|
10.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2007-0818, NCT00756470
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: 110264, NSABP FB-6, NCT00849472
|
|
12.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: XL184-203, NCT00940225
|
|
13.
|
Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: DUMC-6883-06-2R1, DUMC-06068, NCT00346229
|
|
14.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: C4-08-001, NCT00891280
|